In line with our finding that the expression of TRDC decreased in the blood of COVID-19 patients, previous studies have suggested decreased proportions of gamma-delta T cells in the blood of hospitalized COVID-19 patients compared to healthy controls (Wilk et al., 2020). The gene discussed is TRDC; the disease is COVID-19.